New insights into diastolic heart failure: Role of diabetes mellitus

American Journal of Medicine

Volumn 116, Issue 5 SUPPL. 1, 2004, Pages 64-75

  Piccini, Jonathan P ^a   Klein, Liviu ^b   Gheorghiade, Mihai ^b   Bonow, Robert O ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LOSARTAN; NITRATE; PERINDOPRIL; SPIRONOLACTONE;

AGING; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE COMPLIANCE; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SODIUM RESTRICTION; SYMPTOMATOLOGY; TREADMILL; WATER DEPRIVATION;

EID: 1542723196     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.10.021     Document Type: Conference Paper

References (109)

1. American Heart Association. 2002 Heart and Stroke Statistical Update. 2003;American Heart Association, Dallas, TX.
2. Miller L.W., Missov E.D. Epidemiology of heart failure. Cardiol Clin. 19:2001;547-555.
3. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 347:2002;1397-1402.
4. Haldeman G.A., Croft J.B., Giles W.H., Rashidee A. Hospitalization of patients with heart failure National Hospital Discharge Survey, 1985 to 1995. Am Heart J. 137:1999;352-360.
5. O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States time for a different approach. J Heart Lung Transplant. 13:1994;S107-S112.
6. Vasan R.S., Benjamin E.J., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure an epidemiologic perspective. J Am Coll Cardiol. 26:1995;1565-1574.
7. Smith G.L., Masoudi F.A., Vaccarino V., et al. Outcomes in heart failure patients with preserved ejection fraction mortality, readmission, and functional decline. J Am Coll Cardiol. 41:2003;1510-1518.
8. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 33:1999;1948-1955.
9. Mosterd A., Hoes A.W., de Bruyne M.C., et al. Prevalence of heart failure and left ventricular dysfunction in the general population the Rotterdam Study. Eur Heart J. 20:1999;447-455.
10. McAlister F.A., Teo K.K., Taher M., et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 138:1999;87-94.
11. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 98:1998;2282-2289.
12. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 38:2001;2101-2113.
13. McKee P.A., Castelli W.P., McNamara P.M., et al. The natural history of congestive heart failure the Framingham study. N Engl J Med. 285:1971;1441-1446.
14. Brutsaert D.L., Sys S.U. Diastolic dysfunction in heart failure. J Card Fail. 3:1997;225-242.
15. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure I. Diagnosis, prognosis, and measurements of diastolic function. Circulation. 105:2002;1387-1393.
16. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J. 19:1998;990-1003.
17. Vasan R.S., Levy D. Defining diastolic heart failure a call for standardized diagnostic criteria. Circulation. 101:2000;2118-2121.
18. Zile M.R., Gaasch W.H., Carroll J.D., et al. Heart failure with a normal ejection fraction is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 104:2001;779-782.
19. Gandhi S.K., Powers J.C., Nomeir A.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 344:2001;17-22.
20. Zile M.R. Heart failure with preserved ejection fraction is this diastolic heart failure? J Am Coll Cardiol. 41:2003;1519-1522.
21. Maisel A.S., McCord J., Nowak R.M., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. J Am Coll Cardiol. 41:2003;2010-2017.
22. Yip G., Wang M., Zhang Y., et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole time for a redefinition? Heart. 87:2002;121-125.
23. Petrie M.C., Caruana L., Berry C., et al. "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart. 87:2002;29-31.
24. Redfield M.M., Jacobsen S.J., Burnett J.C. Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic. JAMA. 289:2003;194-202.
25. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. for the Cardiovascular Health Study Research Group Importance of heart failure with preserved systolic function in patients ≥65 years of age. Am J Cardiol. 87:2001;413-419.
26. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly the Cardiovascular Health Study. J Am Coll Cardiol. 35:2000;1628-1637.
27. Lindenfeld J., Krause-Steinrauf H., Salerno J. Where are all the women with heart failure? J Am Coll Cardiol. 30:1997;1417-1419.
28. Philbin E.F., Rocco T.A., Lindenmuth N.W., et al. Systolic versus diastolic heart failure in community practice clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med. 109:2000;605-613.
29. Pernenkil R., Vinson J.M., Shah A.S., et al. Course and prognosis in patients ≥70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol. 79:1997;216-219.
30. Judge K.W., Pawitan Y., Caldwell J., et al. Congestive heart failure symptoms in patients with preserved left ventricular systolic function analysis of the CASS registry. J Am Coll Cardiol. 18:1991;377-382.
31. O'Connor C.M., Gattis W.A., Shaw L., et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol. 86:2000;863-867.
32. Rich M.W., McSherry F., Williford W.O., et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure the DIG Study. J Am Coll Cardiol. 38:2001;806-813.
33. Tarantini L., Faggiano P., Senni M., et al. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists data from the Italian Network on Congestive Heart Failure. Ital Heart J. 3:2002;656-664.
34. McDermott M.M., Feinglass J., Lee P.I., et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J. 134:1997;728-736.
35. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiologic characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 288:2002;2144-2150.
36. Chen H.H., Lainchbury J.G., Senni M., et al. Diastolic heart failure in the community clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail. 8:2002;279-287.
37. McDermott M.M., Feinglass J., Sy J., et al. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function clinical characteristics and drug therapy. Am J Med. 99:1995;629-635.
38. Choudhury L., Gheorghiade M., Bonow R.O. Coronary artery disease in patients with heart failure and preserved systolic function. Am J Cardiol. 89:2002;719-722.
39. McDonald I.G. The shape and movements of the human left ventricle during systole a study by cineangiography and by cineradiography of epicardial markers. Am J Cardiol. 26:1970;221-230.
40. Ingels N.B., Daughters G.T., Stinson E.B., et al. Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers. Circulation. 52:1975;859-867.
41. Buckberg G.D. Basic science review the helix and the heart. J Thorac Cardiovasc Surg. 124:2002;863-883.
42. Waldman L.K., Nosan D., Villarreal F., et al. Relation between transmural deformation and local myofiber direction in canine left ventricle. Circ Res. 63:1988;550-562.
43. Rothfeld J.M., LeWinter M.M., Tischler M.D. Left ventricular systolic torsion and early diastolic filling by echocardiography in normal humans. Am J Cardiol. 81:1998;1465-1469.
44. Michelfelder E.C., Khoury P., Witt S.A., et al. Noncircumferential myofiber function impact on early diastolic filling in children. J Am Soc Echocardiogr. 14:2001;1065-1069.
45. Rademakers F.E., Buchalter M.B., Rogers W.J., et al. Dissociation between left ventricular untwisting and filling accentuation by catecholamines. Circulation. 85:1992;1572-1581.
46. Udelson J.E., Bacharach S.L., Cannon R.O. III, et al. Minimum left ventricular pressure during beta-adrenergic stimulation in human subjects evidence for elastic recoil and diastolic "suction" in the normal heart. Circulation. 82:1990;1174-1182.
47. Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure mechanisms and management. Ann Intern Med. 117:1992;502-510.
48. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure II. Causal mechanisms and treatment. Circulation. 105:2002;1503-1508.
49. Nayler W.G., Poole-Wilson P.A., Williams A. Hypoxia and calcium. J Mol Cell Cardiol. 11:1979;683-706.
50. Henry P.D., Schuchleib R., Davis J., et al. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol. 233:1977;H677-H684.
51. Weisfeldt M.L., Armstrong P., Scully H.E., et al. Incomplete relaxation between beats after myocardial hypoxia and ischemia. J Clin Invest. 53:1974;1626-1636.
52. Sordahl L.A., McCollum W.B., Wood W.G., et al. Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure. Am J Physiol. 224:1973;497-502.
53. Ito Y., Suko J., Chidsey C.A. Intracellular calcium and myocardial contractility V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts. J Mol Cell Cardiol. 6:1974;237-247.
54. Gwathmey J.K., Copelas L., MacKinnon R., et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 61:1987;70-76.
55. Zile M.R., Gaasch W.H. Load-dependent left ventricular relaxation in conscious dogs. Am J Physiol. 261:1991;H691-H699.
56. Vitarelli A., Gheorghiade M. Diastolic heart failure standard Doppler approach and beyond. Am J Cardiol. 81:1998;G115-G121.
57. Bell S.P., Nyland L., Tischler M.D., et al. Alterations in the determinants of diastolic suction during pacing tachycardia. Circ Res. 87:2000;235-240.
58. Cazorla O., Freiburg A., Helmes M., et al. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ Res. 86:2000;59-67.
59. Zile M.R., Richardson K., Cowles M.K., et al. Constitutive properties of adult mammalian cardiac muscle cells. Circulation. 98:1998;567-579.
60. Jalil J.E., Doering C.W., Janicki J.S., et al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 64:1989;1041-1050.
61. Weber K.T., Janicki J.S., Pick R., et al. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol. 65:1990;G1-G7.
62. Kato S., Spinale F.G., Tanaka R., et al. Inhibition of collagen cross-linking effects on fibrillar collagen and ventricular diastolic function. Am J Physiol. 269:1995;H863-H868.
63. Brutsaert D.L., Fransen P., Andries L.J., et al. Cardiac endothelium and myocardial function. Cardiovasc Res. 38:1998;281-290.
64. Burkhoff D., Maurer M.S., Packer M. Heart failure with a normal ejection fraction is it really a disorder of diastolic function? Circulation. 107:2003;656-658.
65. Massie B.M. Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure good news and bad. J Am Coll Cardiol. 41:2003;2018-2021.
66. Miller T.R., Grossman S.J., Schectman K.B., et al. Left ventricular diastolic filling and its association with age. Am J Cardiol. 58:1986;531-535.
67. Bonow R.O., Vitale D.F., Bacharach S.L., et al. Effects of aging on asynchronous left ventricular regional function and global ventricular filling in normal human subjects. J Am Coll Cardiol. 11:1988;50-58.
68. White M., Leenen F.H. Aging and cardiovascular responsiveness to beta-agonist in humans role of changes in beta-receptor responses versus baroreflex activity. Clin Pharmacol Ther. 56:1994;543-553.
69. Lakatta E.G., Yin F.C. Myocardial aging functional alterations and related cellular mechanisms. Am J Physiol. 242:1982;H927-H941.
70. O'Rourke M.F. Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance. J Am Coll Cardiol. 38:2001;803-805.
71. Waddell T.K., Dart A.M., Gatzka C.D., et al. Women exhibit a greater age-related increase in proximal aortic stiffness than men. J Hypertens. 19:2001;2205-2212.
72. Levy D., Larson M.G., Vasan R.S., et al. The progression from hypertension to congestive heart failure. JAMA. 275:1996;1557-1562.
73. Lamb H.J., Beyerbacht H.P., van der Laarse A., et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation. 99:1999;2261-2267.
74. Zhang J., McDonald K.M. Bioenergetic consequences of left ventricular remodeling. Circulation. 92:1995;1011-1019.
75. Yelamarty R.V., Moore R.L., Yu F.T., et al. Relaxation abnormalities in single cardiac myocytes from renovascular hypertensive rats. Am J Physiol. 262:1992;C980-C990.
76. Leite-Moreira A.F., Correia-Pinto J., Gillebert T.C. Afterload induced changes in myocardial relaxation a mechanism for diastolic dysfunction. Cardiovasc Res. 43:1999;344-353.
77. Sadoshima J., Xu Y., Slayter H.S., et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
78. Van Heugten H.A., De Jonge H.W., Bezstarosti K., et al. Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes. Ann N Y Acad Sci. 752:1995;343-352.
79. Gaasch W.H. Congestive heart failure in patients with normal left ventricular systolic function a manifestation of diastolic dysfunction. Herz. 16:1991;22-32.
80. Labovitz A.J., Lewen M.K., Kern M., et al. Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J Am Coll Cardiol. 10:1987;748-755.
81. Mahmarian J.J., Pratt C.M. Silent myocardial ischemia in patients with coronary artery disease possible links with diastolic left ventricular dysfunction. Circulation. 81:1990;III33-III40.
82. Poulsen S.H., Jensen S.E., Egstrup K. Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction. Am Heart J. 137:1999;910-918.
83. Humphrey L.S., Topol E.J., Rosenfeld G.I., et al. Immediate enhancement of left ventricular relaxation by coronary artery bypass grafting intraoperative assessment. Circulation. 77:1988;886-896.
84. Bonow R.O., Vitale D.F., Bacharach S.L., et al. Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease reversal after coronary angioplasty. Circulation. 71:1985;297-307.
85. Gorcsan J. III, Diana P., Lee J., et al. Reversible diastolic dysfunction after successful coronary artery bypass surgery assessment by transesophageal Doppler echocardiography. Chest. 106:1994;1364-1369.
86. Pardaens K., Van Cleemput J., Vanhaecke J., et al. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart. 78:1997;564-568.
87. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure the Framingham study. Am J Cardiol. 34:1974;29-34.
88. Parker A.B., Yusuf S., Naylor C.D. The relevance of subgroup-specific treatment effects the Studies Of Left Ventricular Dysfunction (SOLVD) revisited. Am Heart J. 144:2002;941-947.
89. Arnold J.M., Yusuf S., Young J., et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation. 107:2003;1284-1290.
90. Seneviratne B.I. Diabetic cardiomyopathy the preclinical phase. BMJ. 1:1977;1444-1446.
91. Raev D.C. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? an echocardiographic study of young type I diabetic patients. Diabetes Care. 17:1994;633-639.
92. Zabalgoitia M., Ismaeil M.F., Anderson L., et al. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 87:2001;320-323.
93. Liu J.E., Palmieri V., Roman M.J., et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults the Strong Heart Study. J Am Coll Cardiol. 37:2001;1943-1949.
94. Uusitupa M., Siitonen O., Aro A., et al. Effect of correction of hyperglycemia on left ventricular function in non-insulin-dependent (type 2) diabetics. Acta Med Scand. 213:1983;363-368.
95. Iribarren C., Karter A.J., Go A.S., et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 103:2001;2668-2673.
96. Liu J.E., Robbins D.C., Palmieri V., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes the Strong Heart Study. J Am Coll Cardiol. 41:2003;2022-2028.
97. Poirier P., Bogaty P., Garneau C., et al. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 24:2001;5-10.
98. Hardin N. The myocardial and vascular pathology of diabetic cardiomyopathy. Coron Artery Dis. 7:1996;99-108.
99. Young M.E., McNulty P., Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes II. Potential mechanisms. Circulation. 105:2002;1861-1870.
100. Rodrigues B., Cam M.C., McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biol Biochem. 180:1998;53-57.
101. Rupp H., Elimban V., Dhalla N.S. Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions. Mol Cell Biochem. 132:1994;69-80.
102. Bristow M.R. Why does the myocardium fail? insights from basic science. Lancet. 352:1998;S8-S14.
103. Depre C., Young M.E., Ying J., et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol. 32:2000;985-996.
104. Golfman L., Dixon I.M., Takeda N., et al. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes. Mol Cell Biochem. 200:1999;15-25.
105. Flarsheim C.E., Grupp I.L., Matlib M.A. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol. 271:1996;H192-H202.
106. Bristow M.R. Etomoxir a new approach to treatment of chronic heart failure. Lancet. 356:2000;1621-1622.
107. Diamant M., Lamb H.J., Groeneveld Y., et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 42:2003;328-335.
108. Yusuf S., Pfeffer M., Swedberg K., et al. for the CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 362:2003;777-781.
109. Wachtell K., Bella J.N., Rokkedal J., et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation. 105:2002;1071-1076.